Orum Therapeutics, Inc.

475830· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

₩57,900+19.50%

2026-08-04

Financials

Valuation Metrics

Orum Therapeutics, Inc.'s Market Cap is ₩1.3T. At end of 2025 it was ₩2.6T. Ranked #268 of 2,436 in KR market (top 11%), #66 of 1,649 on KOSDAQ (top 4%), #31 of 234 in Pharmaceuticals, Biotechnology & Life Sciences (top 13%) by Market Cap.

Investment Metrics(as of 2026-08-04)

Metric	Value	Rank
Size
Market Cap	1.26T KRW	KR#268/2,436 Sec#31/234
Revenue	20.6M KRW	KR#2,402/2,436 Sec#228/234
Net Income	-48.65B KRW	KR—/2,436 Sec—/234
Total Assets	312.82B KRW	KR#999/2,436 Sec#68/234
Net Assets	119.57B KRW	KR#1,280/2,436 Sec#102/234
Value
P/B	10.52x	KR#2,350/2,436 Sec#211/234
P/S	53367.50x	KR#2,422/2,436 Sec#231/234
Profitability
ROE	-40.68%	KR#2,229/2,436 Sec#188/234
ROA	-15.55%	KR#2,182/2,436 Sec#170/234
Op. Margin	-292397.82%	KR#2,403/2,436 Sec#229/234
Revenue Growth	-100.00%	KR#2,349/2,436 Sec#214/234
Financial Health
Debt Ratio	161.62%	KR#1,339/2,436 Sec#153/234
Total Debt	12.40B KRW	KR#1,544/2,436 Sec#138/234
Cash	113.10B KRW	KR#426/2,436 Sec#20/234
Current Ratio	1.63x	KR#1,202/2,436 Sec#132/234
Performance
1Y Return	163.18%	KR#67/2,436 Sec#4/234
1M Return	10.92%	KR#258/2,436 Sec#16/234
From 52W High	-60.50%	KR#1,730/2,436 Sec#146/234
1Y MDD	-73.70%	KR#2,090/2,436 Sec#188/234
Trading
Volume	310,331 shares	KR#387/2,436 Sec#41/234
Foreign Own.	7.04%	KR#629/2,436 Sec#60/234
Per Share
EPS	-2,264 KRW	KR—/2,436 Sec—/234
BPS	5,236 KRW	KR#1,402/2,436 Sec#101/234